As per Future Market Insights, the continuous positive airway pressure (CPAP) market is anticipated to attain a value pool of US$ 500 million by the end of 2023. Global demand for continuous positive airway pressure is expected to rise at a CAGR of 6% to US$ 900 million in 2033.
| Data Points | Key Statistics |
|---|---|
| Expected Market Value of Continuous Positive Airway Pressure (CPAP) in 2023 | US$ 500 million |
| Projected Market Value of Continuous Positive Airway Pressure (CPAP) in 2033 | US$ 900 million |
| Growth Rate (2023 to 2033) | 6% CAGR |
An alarming rise in the number of chronic obstructive pulmonary disorder (COPD) and a rapid visible increase in the diagnosis rate of sleep apnea/hypopnea syndrome (SAHS), are further complemented by the expanding geriatric population. The demand for lung pulmonary airway disease treatment is also on the rise.
While these factors collectively contribute towards the demand for respiratory assistance therapy and devices, particularly continuous positive airway pressure (CPAP), the recently declared global COVID-19 pandemic is observed to be a solid booster to the global CPAP market landscape.
Moreover, technological advances such as improved mask designs continue to account for accelerating demand for CPAP devices. Design innovations are primarily driven by lack of 100% comfort wearing these masks, as reported by patients over the years.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Continuous positive airway pressure is in high demand, driven by several factors, including the growing prevalence of sleep apnea, increased awareness about sleep disorders, and the increasing demand for home-based treatment options.
The market is also being influenced by the growing demand for connected devices, which allow patients to monitor their sleep patterns and provide real-time data to healthcare providers. The CPAP market is also driven by the increasing focus on patient comfort, with manufacturers incorporating features such as heated humidifiers and noise-reducing technology into their devices.
Increasing focus on patient comfort, as manufacturers are incorporating features such as heated humidifiers and noise-reducing technology into their devices presents potential opportunities for the market. The rise of telemedicine and telehealth has created new opportunities for remote patient monitoring and remote diagnoses, which can benefit the CPAP market.
Continuous positive airway pressure in the Asia Pacific region is experiencing rapid growth due to the increasing prevalence of sleep apnea and the increasing awareness about sleep disorders. The growing demand for home-based sleep apnea treatments and the increasing focus on patient comfort are also contributing to the growth of the CPAP market in the Asia Pacific region. The increasing number of sleep clinics and sleep centers in the region is providing patients with easier access to CPAP therapy. The Asia Pacific CPAP market is expected to continue growing in the coming years, due to the increasing demand for sleep apnea treatment and the increasing focus on patient comfort.
Principal Consultant
The most lucrative end-use area in the continuous positive airway pressure (CPAP) market is likely to be home care settings. The increasing demand for home-based sleep apnea treatments and the growing trend towards patient-centered care are driving the demand for CPAP devices for home use. Patients are increasingly seeking the convenience and comfort of being able to manage their sleep apnea therapy from the comfort of their own homes, and the growing availability of compact and portable CPAP devices is making this option more accessible.
The increasing focus on remote patient monitoring and telehealth has created new opportunities for the home-based CPAP market, as patients are able to use connected devices to monitor their sleep patterns and share real-time data with their healthcare providers. The growing demand for home-based CPAP therapy is expected to continue driving growth in the market in the coming years.
The CPAP market is highly competitive, with a large number of established players and new entrants vying for market share and customer loyalty.
Recent Developments:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Continuous positive airway pressure machines are typically utilized as assistive/supportive and preventive devices to treat patients of SAHS, acute asthma, cardiogenic pulmonary edema, congestive heart failure, chronic lung disease (CLD), cystic fibrosis, and COPD treatment. Of late, they are finding application in providing breathing assistance, rather, as a potential substitute for ventilator.
After the FDA’s recent emergency policy, various alternative respiratory devices emerged to be used as potential replacers for lifesaving ventilators. In light of shortages of ventilators that quickly began to influence the scenario at hospitals and emergency response centers during the novel coronavirus pandemic, CPAP devices started witnessing greater preference among others in the category.
However, as suggested by the American Society of Anesthesiologists’ guidance, utilization of such non-invasive respiratory devices must be subject to additional caution as it is often prone to dispersal of unfiltered droplets, eventually adding to the air-borne infection of virus.
Although the increasingly significant role of CPAP in providing rapid and cost-competitive treatment to COVID-19 patients is placing it much beyond its traditional areas of application, it becomes imperative to comprehend its actual scope of application and viability in these times.
Looking at the existing shortcomings of CPAP in effectively compensating for the undersupply of ventilators, it is of paramount importance to keep abreast of the latest innovations entering the CPAP space.
With industry behemoths such as GE Healthcare and Medtronic ramping up their ventilator production, the latter expects over 40% rise in its global production levels in the near future. The former, on the other side, announced the plan of establishment of its multiple manufacturing facilities in the following years. ResMed also recently revealed its significant production capacity expansion, in collaboration with Tesla, during the past three months.
Future Market Insights (FMI), in this pipeline report, provides a deep-dive analysis of the global CPAP market. In addition to offering a detailed assessment of the key market dynamics and the forthcoming opportunities facing potential investors, the report predominantly covers the impact of novel coronavirus outbreak on the various CPAP market elements over the course of near future.
CPAP machines are being effectively used in treating COVID-19 patients with less severe issues with breathing. However, experts opine that these CPAP machines are themselves capable of aiding the spread of infection irrespective of at hospitals or home care settings.
Aerosolization of the coronavirus due to CPAP masks remains a major concern, which adds to the scepticism regarding adoption of CPAP as a substitute for ventilator. Research shows that face masks that are used for CPAP or bilevel PAP (BiPAP) tend to let air escape, along with the virus, eventually infecting others in the vicinity, including healthcare providers, and patients.
The most commonly observed side effects of CPAP include the claustrophobic feeling under masks, runny nose, nasal congestion, and a greater risk of contamination due to aerosol generation. These factors prevail as key challenges to wider recommendation of CPAP devices.
Moreover, the paucity of patient compliance during diagnosis and treatment will remain a hindrance to broader adoption of CPAP units. Expensive price point of respiratory assistance devices, CPAP therapy administration and associated products also stands as an impediment to skyrocketing demand.
However, the market is recently witnessing an influx of novel innovations that decently attempt to present competitively priced products with a better comfort quotient. Rapid turnaround and mass production compatibility are currently the top parameters on the minds of these innovators to cater to respiratory assistance needs of COVID-19 patients at the earliest.
This FMI study, in addition to providing some solid actionable insights on the increasingly significant role of CPAP machines in combating the coronavirus crisis, offers information on the latest developments of market leaders in this regard.
Some of the prominent companies active in the global CPAP market landscape that are profiled in the report include ResMed, Koninklijke Philips, Medtronic, Armstrong Medical Inc., Smiths Medical, Cardinal Health, Apex Medical Corp., Koike Medical, DeVilbiss Healthcare LLC, Beijing Dehaier Medical Technology, Teijin Pharma, BMC Medical, Fosun Pharma, 3B Medical, Inc., Fisher & Phillips LLP, and Invacare Corporation.
The global market landscape continues to reflect a fragmented nature, yet continues to witness primacy of leading international players. Product features, competitive pricing structure, and reliability act as the key differentiating touchpoints for companies competing in the market.
Recently, a British Formula 1 engine manufacturer - Mercedes-AMG High Performance Powertrains (Northamptonshire), developed an efficient breathing aid in form of a CPAP unit to respond to the expected rise in COVID-19 patients with breathing difficulties. This device has been developed through reverse engineering one of their existing devices, and it definitely eliminates the need for a ventilator.
Explore Healthcare Insights
View Reports
Continuous Positive Airway Pressure (CPAP) Market
